356 related articles for article (PubMed ID: 33538202)
1. The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectives.
Iznardo H; Puig L
Expert Rev Clin Immunol; 2021 Feb; 17(2):187-199. PubMed ID: 33538202
[No Abstract] [Full Text] [Related]
2. Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease.
Iznardo H; Puig L
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919434
[TBL] [Abstract][Full Text] [Related]
3. IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications.
Iznardo H; Puig L
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012744
[TBL] [Abstract][Full Text] [Related]
4. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases.
Walsh PT; Fallon PG
Ann N Y Acad Sci; 2018 Apr; 1417(1):23-34. PubMed ID: 27783881
[TBL] [Abstract][Full Text] [Related]
5. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target.
Botti E; Spallone G; Caruso R; Monteleone G; Chimenti S; Costanzo A
Curr Pharm Biotechnol; 2012 Aug; 13(10):1861-7. PubMed ID: 22250707
[TBL] [Abstract][Full Text] [Related]
7. Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNFalpha.
MclInnes IB
Ernst Schering Res Found Workshop; 2006; (56):29-44. PubMed ID: 16329645
[TBL] [Abstract][Full Text] [Related]
8. Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis.
Furue K; Yamamura K; Tsuji G; Mitoma C; Uchi H; Nakahara T; Kido-Nakahara M; Kadono T; Furue M
Acta Derm Venereol; 2018 Jan; 98(1):5-13. PubMed ID: 28967976
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 cytokines: Effectors and targets in psoriasis-A breakthrough in understanding and treatment.
Prinz I; Sandrock I; Mrowietz U
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727784
[TBL] [Abstract][Full Text] [Related]
10. Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis.
Burden AD
Expert Rev Clin Immunol; 2023 May; 19(5):473-481. PubMed ID: 36960829
[TBL] [Abstract][Full Text] [Related]
11. The enigmatic role of IL-38 in inflammatory diseases.
Garraud T; Harel M; Boutet MA; Le Goff B; Blanchard F
Cytokine Growth Factor Rev; 2018 Feb; 39():26-35. PubMed ID: 29366546
[TBL] [Abstract][Full Text] [Related]
12. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.
Siebert S; Tsoukas A; Robertson J; McInnes I
Pharmacol Rev; 2015; 67(2):280-309. PubMed ID: 25697599
[TBL] [Abstract][Full Text] [Related]
13. The role of IL 23 in the treatment of psoriasis.
Puig L
Expert Rev Clin Immunol; 2017 Jun; 13(6):525-534. PubMed ID: 28165883
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-based therapy in psoriasis.
Mitra A; Fallen RS; Lima HC
Clin Rev Allergy Immunol; 2013 Apr; 44(2):173-82. PubMed ID: 22426927
[TBL] [Abstract][Full Text] [Related]
15. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
Novelli L; Chimenti MS; Chiricozzi A; Perricone R
Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
[TBL] [Abstract][Full Text] [Related]
16. Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity.
Samotij D; Szczęch J; Reich A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445754
[TBL] [Abstract][Full Text] [Related]
17. Autoinflammatory process in the pathogenesis of generalized pustular psoriasis and perspectives of its targeted therapy.
Javor J; Buc M; Bucová M
Epidemiol Mikrobiol Imunol; 2021; 70(3):199-207. PubMed ID: 34641694
[TBL] [Abstract][Full Text] [Related]
18. IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential.
Boutet MA; Nerviani A; Pitzalis C
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871134
[TBL] [Abstract][Full Text] [Related]
19. Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice.
Chen L; Deshpande M; Grisotto M; Smaldini P; Garcia R; He Z; Gulko PS; Lira SA; Furtado GC
Sci Rep; 2020 May; 10(1):8259. PubMed ID: 32427877
[TBL] [Abstract][Full Text] [Related]
20. Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis.
Alunno A; Carubbi F; Cafaro G; Pucci G; Battista F; Bartoloni E; Giacomelli R; Schillaci G; Gerli R
Expert Opin Biol Ther; 2015; 15(12):1727-37. PubMed ID: 26653110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
